Post Date:Jul-20-20
EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer
Author: AcceGen R&D TeamDate Published: 20-Jul-20
EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer
- Authors: Vito Amodio, Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato, Sabrina Arena, Monica Montone, Benedetta Mussolin, Yu Bian, Adele Whaley, Marika Pinnelli, Yonina R Murciano-Goroff, Efsevia Vakiani, Nicola Valeri, Wei-Li Liao, Anuja Bhalkikar, Sheeno Thyparambil, Hui-Yong Zhao, Elisa de Stanchina, Silvia Marsoni, Salvatore Siena, Andrea Bertotti, Livio Trusolino, Bob T. Li, Neal Rosen, Federica Di Nicolantonio, Alberto Bardelli and Sandra Misale
- Journal: Cancer Discovery
- DOI: 10.1158/2159-8290.CD-20-0187
- Cited AcceGen Product/Service:
Copyright - Unless otherwise stated all contents of this website are AcceGen™ All Rights Reserved – Full details of the use of materials on this site please refer to AcceGen Editorial Policy – Guest Posts are welcome, by submitting a guest post to AcceGen you are agree to the AcceGen Guest Post Agreement – Any concerns please contact marketing@accegen.com
